7Baggers
 minerva neurosciences provides business updates and second quarter financial results  Investing News Network Sun, 14 Sep 2025 00:13:16 GMT
 risk vs reward if holding onto minerva neurosciences inc.  Newser Mon, 08 Sep 2025 07:37:02 GMT
 neurology biopharmas rebound on trial catalysts and q2 gains  BioWorld MedTech Fri, 05 Sep 2025 07:00:00 GMT

Minerva Neurosciences, Inc
(NASDAQ:NERV) 

NERV stock logo

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, a compound in Phase III clinical trial for the treatment o...

Founded: 2007
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends